✦ LIBER ✦

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects

✍ Scribed by Yoshikatsu Kanai; MatthiasA. Hediger

Publisher: Springer
Year: 2004
Tongue: English
Weight: 338 KB
Volume: 447
Category: Article
ISSN: 0031-6768
DOI: 10.1007/s00424-003-1146-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exclusion of linkage between schizophren

Exclusion of linkage between schizophrenia and the gene encoding a neutral amino acid glutamate/aspartate transporter, SLC1A5

✍ Chen, Andrew Chih-Hui; Kalsi, Gursharan; Brynjolfsson, Jon; Sigmundsson, Thordur 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

An abnormality in glutamatergic function has been hypothesized as being of etiological importance in schizophrenia. Twentythree multiplex English and Icelandic schizophrenia families were genotyped with a polymorphic dinucleotide repeat sequence in the 3Ј-untranslated region of the glutamate/ aspart

The role of the neutral amino acid trans

The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition

✍ Stefan Bröer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

## Abstract Hartnup disorder (OMIM 234500) is an autosomal recessive disorder, which was first described in 1956 as an aminoaciduria of neutral amino acids accompanied by a variety of symptoms, such as a photo‐sensitive skin‐rash and cerebellar ataxia. The disorder is caused by mutations in the neu